dr. zhang on the arches trial in prostate cancer
Published 6 years ago • 328 plays • Length 1:03Download video MP4
Download video MP3
Similar videos
-
1:27
dr. zhang discusses the impact of the stampede trial in prostate cancer
-
1:32
dr. zhang on the impact of the latitude study in prostate cancer
-
1:41
dr. zhang on therapeutic advancements in prostate cancer
-
1:18
dr. armstrong discusses arches trial in prostate cancer
-
1:38
dr. armstrong discusses findings of arches trial in prostate cancer
-
1:08
dr. zhang on the importance of adjuvant clinical trials in rcc
-
5:11
enzalutamide adt in men with de novo mhspc: the arches trial
-
1:17
tian zhang, md, on the evolving landscape of metastatic hormone-sensitive prostate cancer
-
6:02
update on the arches trial: new indication for enzalutamide in mhspc
-
0:52
mark t. fleming, md, on the arches trial in metastatic hormone-sensitive prostate cancer
-
3:57
update on arches trial: implications for prostate cancer treatment
-
1:55
arches trial overview: adt plus enzalutamide for metastatic hormone-sensitive prostate cancer
-
2:49
dr. cheng on the goals of the gentlemen trial in prostate cancer
-
2:04
update on overall survival in arches trial
-
3:43
arches trial: androgen deprivation therapy with enzalutamide or placebo in mhspc
-
1:11
dr. zhang on toxicities of treatments in rcc
-
2:37
arches trial: enzalutamide plus adt for mhspc
-
2:18
arches: enzalutamide plus adt in mhspc subgroups
-
1:35
arches: os by high or low disease volume and progression to mhspc or de novo mhspc